Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 6, 2011

Premium

Advent Venture Partners has named Dale Pfost as a venture partner.

Pfost previously served as CEO and chairman of Acuity Pharmaceuticals, an siRNA-based drug developer that was later acquired by Opko Health.


Regulus Therapeutics has promoted Garry Menzel to COO and executive vice president of finance.

He previously served as executive vice president of corporate development and finance. Before joining Regulus, Menzel was a managing director at Credit Suisse. Before that, he was a managing director at Goldman Sachs.

He has a BSc in biochemistry from the Imperial College of Science & Technology, and a PhD in molecular biology from the University of Cambridge. He also received an MBA from the Stanford Graduate School of Business.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.